Gustave F. Perna
Search results
People also ask
Who is Moncef Mohamed Slaoui?
Where did Slaoui go to medical school?
Who is Dr Slaoui & why did he join operation warp speed?
Is Moncef Slaoui a conflict of interest?
Slaoui's doctoral advisor was immunologist Jacques Urbain. Slaoui took postgraduate courses at Harvard Medical School and the Tufts University School of Medicine without earning degrees. In 1998, he received an accelerated MBA from the International Institute for Management Development (IMD) in Lausanne, Switzerland. Career
Slaoui earned an undergraduate degree in biology and a PhD in molecular biology and immunology from Free University of Brussels. He came to the United States to pursue postdoctoral studies at Harvard Medical School and Tufts University School of Medicine.
- Dr. Moncef Slaoui Biography
- Moncef Slaoui Education
- Moncef Slaoui Wife
- Moncef Slaoui Immunologist
- Dr. Moncef Slaoui Vaccine
- Moncef Slaoui GSK
- Moncef Slaoui Moderna
- Moncef Slaoui Coronavirus
- Moncef Slaoui Operation Warp Speed
Moncef Slaoui is an immunologist who served as a former chairman of vaccines at GlaxoSmithKline and head of Pharma R & D. In May 2020 he was appointed by President Donald Trump as the chief adviser of Operation Warp Speed, the government’s effort to speed up the development of a vaccine for the coronavirus.
Slaoui has a Ph.D. in Molecular Biology and Immunology from the Université Libre de Bruxelles in Belgium. He has a doctorate from Harvard Medical School and Tufts University School of Medicine in Boston.
Dr. Moncef is married to Kristen E. Belmonte Slaouiwho is the Vice President and Head of Business Development for GlaxoSmithKline’s (GSK) Pharmaceuticals Commercial Portfolio. She joined GSK’s Business Development team in 2006. She previously held a position in Respiratory Drug Discovery. She graduated from Gettysburg College with a Bachelor’s degr...
Moncef is an immunologist. He was a professor of Immunology at the University of Mons, Belgium and has authored more than 100 scientific papers and presentations.
Moncef has a passion for vaccine development as it is personal for him. His sister died from whooping cough, an immunizable disease, while they were growing up in Morocco. He is credited for a cervical-cancer vaccine and a pneumococcal immunization. In 2015 he won European approval for the world’s first malaria vaccine.
Moncef is a former chairman of GlaxoSmithKline (GSK) global vaccines and Head of Pharmaceutical R&D. He joined the company in 1988 as a bench scientist. He also served on its Board of Directors for 11 years and led its global pharmaceutical R&D activities from 2006 through to 2015. His previous roles included Chairman of Global Research and Develop...
Dr. Moncef served as a member of Moderna’s Board of Directors since 2017. He resigned in May 2020 after he was appointed by President Donald Trump to oversee the White House’s Operation Warp Speed Initiative. Moderna, Inc., is a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation...
In March 2020 Morocco World Newsreported that Moncef denied in a statement to Moroccan French-language newspaper L’Economiste that he was part of a US government task force to find a vaccine for COVID-19. He said that he was a part of Moderna’s research and development committee. The committee has received support from federal organizations to help...
Dr. Moncef was appointed by President Donald Trump in May 2020 to lead Operation Warp Speed, the government’s effort to speed up the development of a vaccine for the coronavirus. He will serve as the chief adviser while Gustave F. Perna will serve as the chief operating officer. President Trump ordered the creation of the Warp Speed program to try ...
Jan 25, 2021 · The decision puzzled immunologist Moncef Slaoui, scientific head of Warp Speed, but he attributes it to a word he says with disdain: politics. Slaoui recently resigned from his post, but has agreed to help the Biden transition team into February.
Dec 1, 2020 · Operation Warp Speed science adviser Moncef Slaoui says that although the vaccine development process has been fairly smooth, he worries people may be leery of a COVID-19 vaccine. Temple ...
Aug 26, 2020 · Developing Safe and Effective Covid Vaccines — Operation Warp Speed’s Strategy and Approach. Authors: Moncef Slaoui, Ph.D., and Matthew Hepburn, M.D. Author Info & Affiliations. Published ...
Mar 24, 2021 · GlaxoSmithKline, the pharmaceutical company, said on Wednesday that it had fired Moncef Slaoui, the former head of Operation Warp Speed, from his position as chairman of Galvani Bioelectronics...
